Moderna (NASDAQ: MRNA) - one to watch when US market opens as COVID-19 vaccine hope after trial produced antibodies in all volunteers.
Sounds like the damage might be done by the time it opens. Boat missed!
1 Like
I agree, as looking at the opening forecast, will miss the boat!
Run Forrest run! 
3 Likes
Already up 13.5% in premarket trading
1 Like
Jumped about 9% and retraced to 8%.
1 Like
9% is too little for me.
1 Like
Whats peoples thoughts on Moderna of late?
1 Like
I’m wondering the same thing.
I see it as a cheap opportunity, even after the COVID pandemic.
Of course the risk is that none of their trials are successful.
The above article mentions that mRNA technologies are largely unproven, but the important flipside to that statement is that some mRNA tech does seem promising.
(Lots of sources:)
They certainly have a lot in the pipeline, as any good pharma company should.
My only concern is that they weren’t making a profit pre-COVID.
Although COVID isn’t going anywhere and vaccines will likely (always) be needed, hopefully the demand for them will be reduced very soon. Will this be enough to keep them in the black?
Maybe the profits from the COVID vaccine has given them enough time to (re-)turn a profit?
What do others think about Moderna?
1 Like